Literature DB >> 15331736

Discrimination among rhinovirus serotypes for a variant ICAM-1 receptor molecule.

Chuan Xiao1, Tobias J Tuthill, Carol M Bator Kelly, Lisa J Challinor, Paul R Chipman, Richard A Killington, David J Rowlands, Alister Craig, Michael G Rossmann.   

Abstract

Intercellular adhesion molecule 1 (ICAM-1) is the cellular receptor for the major group of human rhinovirus serotypes, including human rhinovirus 14 (HRV14) and HRV16. A naturally occurring variant of ICAM-1, ICAM-1Kilifi, has altered binding characteristics with respect to different HRV serotypes. HRV14 binds to ICAM-1 only transiently at physiological temperatures but forms a stable complex with ICAM-1Kilifi. Conversely, HRV16 forms a stable complex with ICAM-1 but does not bind to ICAM-1Kilifi. The three-dimensional structures of HRV14 and HRV16, complexed with ICAM-1, and the structure of HRV14, complexed with ICAM-1Kilifi, have been determined by cryoelectron microscopy (cryoEM) image reconstruction to a resolution of approximately 10 angstroms. Structures determined by X-ray crystallography of both viruses and of ICAM-1 were fitted into the cryoEM density maps. The interfaces between the viruses and receptors contain extensive ionic networks. However, the interactions between the viruses and ICAM-1Kilifi contain one less salt bridge than between the viruses and ICAM-1. As HRV16 has fewer overall interactions with ICAM-1 than HRV14, the absence of this charge interaction has a greater impact on the binding of ICAM-1Kilifi to HRV16 than to HRV14. Copyright 2004 American Society for Microbiology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331736      PMCID: PMC514980          DOI: 10.1128/JVI.78.18.10034-10044.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  X-ray structure of a minor group human rhinovirus bound to a fragment of its cellular receptor protein.

Authors:  Nuria Verdaguer; Ignacio Fita; Manuela Reithmayer; Rosita Moser; Dieter Blaas
Journal:  Nat Struct Mol Biol       Date:  2004-04-04       Impact factor: 15.369

2.  Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound.

Authors:  B A Heinz; R R Rueckert; D A Shepard; F J Dutko; M A McKinlay; M Fancher; M G Rossmann; J Badger; T J Smith
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

3.  Structure of a human common cold virus and functional relationship to other picornaviruses.

Authors:  M G Rossmann; E Arnold; J W Erickson; E A Frankenberger; J P Griffith; H J Hecht; J E Johnson; G Kamer; M Luo; A G Mosser
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

4.  The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating.

Authors:  T J Smith; M J Kremer; M Luo; G Vriend; E Arnold; G Kamer; M G Rossmann; M A McKinlay; G D Diana; M J Otto
Journal:  Science       Date:  1986-09-19       Impact factor: 47.728

5.  Structural analysis of a series of antiviral agents complexed with human rhinovirus 14.

Authors:  J Badger; I Minor; M J Kremer; M A Oliveira; T J Smith; J P Griffith; D M Guerin; S Krishnaswamy; M Luo; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

6.  Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors.

Authors:  D C Pevear; M J Fancher; P J Felock; M G Rossmann; M S Miller; G Diana; A M Treasurywala; M A McKinlay; F J Dutko
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

7.  The major human rhinovirus receptor is ICAM-1.

Authors:  J M Greve; G Davis; A M Meyer; C P Forte; S C Yost; C W Marlor; M E Kamarck; A McClelland
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

8.  The binding site on ICAM-1 for Plasmodium falciparum-infected erythrocytes overlaps, but is distinct from, the LFA-1-binding site.

Authors:  A R Berendt; A McDowall; A G Craig; P A Bates; M J Sternberg; K Marsh; C I Newbold; N Hogg
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

9.  Structural and functional analysis of integrin alpha2I domain interaction with echovirus 1.

Authors:  Li Xing; Mikko Huhtala; Vilja Pietiäinen; Jarmo Käpylä; Kirsi Vuorinen; Varpu Marjomäki; Jyrki Heino; Mark S Johnson; Timo Hyypiä; R Holland Cheng
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

10.  Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus.

Authors:  D J Filman; R Syed; M Chow; A J Macadam; P D Minor; J M Hogle
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more
  13 in total

1.  Seneca Valley virus attachment and uncoating mediated by its receptor anthrax toxin receptor 1.

Authors:  Lin Cao; Ran Zhang; Tingting Liu; Zixian Sun; Mingxu Hu; Yuna Sun; Lingpeng Cheng; Yu Guo; Sheng Fu; Junjie Hu; Xiangmin Li; Chengqi Yu; Hanyang Wang; Huanchun Chen; Xueming Li; Elizabeth E Fry; David I Stuart; Ping Qian; Zhiyong Lou; Zihe Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-04       Impact factor: 11.205

2.  Engineering of single Ig superfamily domain of intercellular adhesion molecule 1 (ICAM-1) for native fold and function.

Authors:  Róisín M Owens; Xiaoling Gu; Miran Shin; Timothy A Springer; Moonsoo M Jin
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

Review 3.  Understanding the Association of Human Rhinovirus with Asthma.

Authors:  Cosby A Stone; E Kathryn Miller
Journal:  Clin Vaccine Immunol       Date:  2015-09-16

4.  ICAM-1 induced rearrangements of capsid and genome prime rhinovirus 14 for activation and uncoating.

Authors:  Dominik Hrebík; Tibor Füzik; Mária Gondová; Lenka Šmerdová; Athanassios Adamopoulos; Ondrej Šedo; Zbyněk Zdráhal; Pavel Plevka
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

5.  Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C.

Authors:  Yury A Bochkov; Ann C Palmenberg; Wai-Ming Lee; Jennifer A Rathe; Svetlana P Amineva; Xin Sun; Thomas R Pasic; Nizar N Jarjour; Stephen B Liggett; James E Gern
Journal:  Nat Med       Date:  2011-04-10       Impact factor: 53.440

6.  Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome.

Authors:  Lucy B Ochola; Bethsheba R Siddondo; Harold Ocholla; Siana Nkya; Eva N Kimani; Thomas N Williams; Johnstone O Makale; Anne Liljander; Britta C Urban; Pete C Bull; Tadge Szestak; Kevin Marsh; Alister G Craig
Journal:  PLoS One       Date:  2011-03-03       Impact factor: 3.240

7.  An analysis of the binding characteristics of a panel of recently selected ICAM-1 binding Plasmodium falciparum patient isolates.

Authors:  Aymen M Madkhali; Mohammed O Alkurbi; Tadge Szestak; Anja Bengtsson; Pradeep R Patil; Yang Wu; Saeed A Al-Harthi; Saeed Alharthi; Anja T R Jensen; Richard Pleass; Alister G Craig
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

8.  Complex structure of engineered modular domains defining molecular interaction between ICAM-1 and integrin LFA-1.

Authors:  Sungkwon Kang; Chae Un Kim; Xiaoling Gu; Roisin M Owens; Sarah J van Rijn; Vanissra Boonyaleepun; Yuxin Mao; Timothy A Springer; Moonsoo M Jin
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

9.  Capsid protein VP4 of human rhinovirus induces membrane permeability by the formation of a size-selective multimeric pore.

Authors:  Anusha Panjwani; Mike Strauss; Sarah Gold; Hannah Wenham; Terry Jackson; James J Chou; David J Rowlands; Nicola J Stonehouse; James M Hogle; Tobias J Tuthill
Journal:  PLoS Pathog       Date:  2014-08-07       Impact factor: 6.823

10.  Variation in the ICAM1 gene is not associated with severe malaria phenotypes.

Authors:  A E Fry; S Auburn; M Diakite; A Green; A Richardson; J Wilson; M Jallow; F Sisay-Joof; M Pinder; M J Griffiths; N Peshu; T N Williams; K Marsh; M E Molyneux; T E Taylor; K A Rockett; D P Kwiatkowski
Journal:  Genes Immun       Date:  2008-06-05       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.